Stock PIII P3 HEALTH PARTNERS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News P3 Health Partners Inc.

Equities

PIII

US7444131053

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
0.59 USD -1.67% Intraday chart for P3 Health Partners Inc. -2.40% -58.16%
May. 22 P3 Health Partners Inc. announced that it expects to receive $42.2598 million in funding from Chicago Pacific Founders CI
May. 08 Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q1 Revenue $388.5M, vs. Street Est of $357.2M MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
P3 Health Partners Inc. Announces Approximately $42.2 Million Private Placement
BU
P3 Health Partners Inc. announced that it expects to receive $42.2598 million in funding from Chicago Pacific Founders
CI
P3 Health Partners Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q1 Revenue $388.5M, vs. Street Est of $357.2M
MT
Transcript : P3 Health Partners Inc., Q1 2024 Earnings Call, May 08, 2024
P3 Health Partners Announces First Quarter 2024 Results
BU
P3 Health Partners Names Dr. Aric Coffman as CEO
BU
P3 Health Partners Inc. Announces CEO Changes
CI
P3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference Call
BU
P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference
BU
BTIG Research Downgrades P3 Health Partners to Neutral From Buy
MT
Transcript : P3 Health Partners Inc., Q4 2023 Earnings Call, Mar 28, 2024
P3 Health Partners Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results
BU
Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q4 Revenue $346.9M, vs. Street Est of $302.7M
MT
P3 Health Partners Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
BU
P3 Health Partners Inc. Reaffirms Earnings Guidance for the full-year ending December 31, 2024
CI
Lake Street Adjusts Price Target on P3 Health Partners to $4.50 From $9, Maintains Buy Rating
MT
P3 Health Partners to Present at the KeyBanc LifeSciences and Medtech Investor Forum
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PIII Stock
  4. News P3 Health Partners Inc.